CDTX:US
$61.85
-1.544%

Cidara Therapeutics Inc.
News & Events

Last updated: Jul 28, 2025, 3:06 AM ET

  1. Cidara Therapeutics to Report Second Quarter 2025 Financial Results and Host Quarterly Conference Call on August 7, 2025

    GlobeNewswire JUL 24, 2025 8:00 AM EDT
    SAN DIEGO, July 24, 2025 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechn...
    READ ARTICLE
  2. Cidara Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

    GlobeNewswire JUL 1, 2025 4:59 PM EDT
    SAN DIEGO, July 01, 2025 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechn...
    READ ARTICLE
  3. Cidara Therapeutics Announces Inclusion in the Russell 2000® and Russell 3000® Indexes

    GlobeNewswire JUN 30, 2025 8:00 AM EDT
    SAN DIEGO, June 30, 2025 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechn...
    READ ARTICLE
  4. Cidara Announces Closing of Upsized Public Offering and Full Exercise of Underwriters' Option to Purchase Additional Shares

    GlobeNewswire JUN 26, 2025 5:15 PM EDT
    SAN DIEGO, June 26, 2025 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (“Cidara”) (...
    READ ARTICLE
  5. Cidara Announces Pricing of Upsized Public Offering of Common Stock

    GlobeNewswire JUN 24, 2025 8:00 PM EDT
    SAN DIEGO, June 24, 2025 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (“Cidara”) (...
    READ ARTICLE
  6. Cidara Announces Proposed Public Offering of Common Stock

    GlobeNewswire JUN 23, 2025 4:15 PM EDT
    SAN DIEGO, June 23, 2025 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (“Cidara”) (...
    READ ARTICLE
  7. Cidara Therapeutics Announces Positive Topline Results from its Phase 2b NAVIGATE Trial Evaluating CD388, a Non-Vaccine Preventative of Seasonal Influenza

    GlobeNewswire JUN 23, 2025 7:00 AM EDT
    The study met its primary and all secondary efficacy endpoints for all dose groups Single...
    READ ARTICLE
  8. Cidara Therapeutics to Host Virtual R&D Day to Discuss CD388 as a Potential Universal, Once-Per-Flu Season Preventative of Seasonal and Pandemic Influenza on May 22, 2025

    GlobeNewswire MAY 15, 2025 8:00 AM EDT
    SAN DIEGO, May 15, 2025 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq: CDTX) (the Company...
    READ ARTICLE
  9. Cidara Therapeutics to Participate in Two Upcoming Investor Conferences

    GlobeNewswire MAY 13, 2025 8:00 AM EDT
    SAN DIEGO, May 13, 2025 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechno...
    READ ARTICLE
  10. Cidara Therapeutics Provides Corporate Update and Reports First Quarter 2025 Financial Results

    GlobeNewswire MAY 8, 2025 4:15 PM EDT
    Data cutoff date for Phase 2b NAVIGATE trial efficacy reached on April 30, 2025; top-line data re...
    READ ARTICLE

Upcoming Events

Get notified of Cidara Therapeutics Inc.’s latest announcements, news, and event dates.
  • Upcoming earnings announcement (Estimated)

    Aug 7, 2025
  • Upcoming dividend payout

    Not Available
  • Upcoming stock splits

    Not Available